Prolactin-induced mouse mammary carcinomas model estrogen resistant luminal breast cancer (original) (raw)

Prolactin induces ERα-positive and ERα-negative mammary cancer in transgenic mice

Lisa Arendt

Oncogene, 2003

View PDFchevron_right

Anti-estrogen therapy increases plasticity and cancer stemness of prolactin-induced ERα+ mammary carcinomas

Vincent Goffin

Cancer research, 2018

View PDFchevron_right

Activation of the unliganded estrogen receptor by prolactin in breast cancer cells

Ana Aranda

Oncogene, 2009

View PDFchevron_right

Loss of mammary epithelial prolactin receptor delays tumor formation by reducing cell proliferation in low-grade preinvasive lesions

James Kench

Oncogene, 2007

View PDFchevron_right

Global profiling of prolactin-modulated transcripts in breast cancer in vivo

Justin Lin

Molecular Cancer, 2013

View PDFchevron_right

Ovarian hormones are not required for PRL-induced mammary tumorigenesis, but estrogen enhances neoplastic processes

Lisa Arendt

Journal of Endocrinology, 2009

View PDFchevron_right

Expression of Prolactin and Its Receptor in Human Breast Carcinoma 1

Jean-jacques Lebrun

Endocrinology, 1997

View PDFchevron_right

Prolactin Drives Estrogen Receptor-α-Dependent Ductal Expansion and Synergizes with Transforming Growth Factor-α to Induce Mammary Tumors in Males

Lisa Arendt

The American Journal of Pathology, 2008

View PDFchevron_right

Estradiol stimulates expression of two human prolactin receptor isoforms with alternative exons-1 in T47D breast cancer cells

Maria Dufau

The Journal of steroid biochemistry and molecular biology, 2002

View PDFchevron_right

Prolactin drives estrogen receptor-alpha-dependent ductal expansion and synergizes with transforming growth factor-alpha to induce mammary tumors in males

Lisa Arendt

The American journal of pathology, 2008

View PDFchevron_right

Role of EGF/ERBB1 in the transcriptional regulation of the prolactin receptor independent of estrogen and prolactin in breast cancer cells

Maria Dufau

Oncotarget, 2016

View PDFchevron_right

Prolactin receptor gene transcriptional control, regulatory modalities relevant to breast cancer resistance and invasiveness

Maria Dufau

Frontiers in Endocrinology

View PDFchevron_right

Increased Expression of Prolactin Receptor Gene Assessed by Quantitative Polymerase Chain Reaction in Human Breast Tumors Versus Normal Breast Tissues

Jean-françois Martini

The Journal of Clinical Endocrinology & Metabolism, 1998

View PDFchevron_right

Should prolactin be reconsidered as a therapeutic target in human breast cancer?

Vincent Goffin

Molecular and Cellular Endocrinology, 1999

View PDFchevron_right

The role of prolactin in human breast cancer Review

Hamza Mujagic

Biochemia Medica

View PDFchevron_right

Human Prolactin Receptor Variants in Breast Cancer: Low Ratio of Short Forms to the Long-Form Human Prolactin Receptor Associated with Mammary Carcinoma

Maria Dufau

Cancer Research, 2004

View PDFchevron_right

Prolactin Drives Estrogen Receptor- -Dependent Ductal Expansion and Synergizes with Transforming Growth Factor- to Induce Mammary Tumors in Males

Lisa Arendt

Amer J Pathol, 2008

View PDFchevron_right

Expression of prolactin receptors in normal canine mammary tissue, canine mammary adenomas and mammary adenocarcinomas

Erika Michel, Iris Reichler

BMC Veterinary Research, 2012

View PDFchevron_right

The role of prolactin in human breast cancer

Hamza Mujagic

2009

View PDFchevron_right

Progestins Initiate a Luminal to Myoepithelial Switch in Estrogen-Dependent Human Breast Tumors without Altering Growth

Carol Sartorius

Cancer Research, 2005

View PDFchevron_right

Investigation of the Link Between Prolactin, Mammary Gland Development and Carcinogenesis by Transcript Profiling

Jessica Harris

2002

View PDFchevron_right

Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status

Matthew Lee-wing

Cancer research, 1987

View PDFchevron_right

Prolactin receptor expression in gynaecomastia and male breast carcinoma

Mariana Mesquita

Histopathology, 2008

View PDFchevron_right

Association of estrogen receptor-α and progesterone receptor A expression with hormonal mammary carcinogenesis: role of the host microenvironment

juan pablo cerliani

Breast Cancer Research, 2007

View PDFchevron_right

Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer

Kishan Patel

Breast (Edinburgh, Scotland), 2018

View PDFchevron_right

Prolactin Potentiates Transforming Growth Factor Induction of Mammary Neoplasia in Transgenic Mice

Eric Sandgren, Lisa Arendt

Amer J Pathol, 2006

View PDFchevron_right

Prolactin Potentiates Transforming Growth Factor α Induction of Mammary Neoplasia in Transgenic Mice

Lisa Arendt

The American Journal of Pathology, 2006

View PDFchevron_right

Estrogen receptor isoforms and progestin hormone dependence in a mouse mammary tumor model

Andrea Actis

International Journal of Cancer, 1994

View PDFchevron_right

Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands

Maria Nagai

BMC Cancer

View PDFchevron_right

The Expression of Prolactin Receptors in Benign Breast Tumors Is Not Associated with Serum Prolactin Level

Roman Moskalenko

Journal of Clinical Medicine, 2021

View PDFchevron_right

Local over-expression of prolactin in differentiating mouse mammary gland induces functional defects and benign lesions, but no carcinoma

Vincent Goffin

Journal of Endocrinology, 2006

View PDFchevron_right

Biological Significance of Prolactin in Gynecologic Cancers

Gil Mor

Cancer Research, 2009

View PDFchevron_right

Five Novel Hormone-responsive Cell Lines Derived from Murine Mammary Ductal Carcinomas: In Vivo and in Vitro Effects of Estrogens and Progestins1

Norberto Sanjuan

Cancer Research, 2001

View PDFchevron_right

Progesterone Receptor Expression in Medroxyprogesterone Acetate-Induced Murine Mammary Carcinomas and Response to Endocrine Treatment

Luisa Helguero, Aroumougame Asaithamby

Breast Cancer Research and Treatment, 2003

View PDFchevron_right